Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolus (EOLS) EBITDA (2018 - 2025)

Evolus' EBITDA history spans 8 years, with the latest figure at $111000.0 for Q4 2025.

  • For Q4 2025, EBITDA rose 101.58% year-over-year to $111000.0; the TTM value through Dec 2025 reached -$50.9 million, changed 0.01%, while the annual FY2025 figure was -$50.9 million, 0.01% changed from the prior year.
  • EBITDA reached $111000.0 in Q4 2025 per EOLS's latest filing, up from -$15.3 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $6.4 million in Q1 2021 to a low of -$23.5 million in Q2 2022.
  • Average EBITDA over 5 years is -$14.3 million, with a median of -$16.3 million recorded in 2021.
  • Peak YoY movement for EBITDA: soared 132.8% in 2021, then tumbled 375.02% in 2022.
  • A 5-year view of EBITDA shows it stood at -$18.2 million in 2021, then rose by 27.75% to -$13.1 million in 2022, then rose by 11.28% to -$11.7 million in 2023, then surged by 39.86% to -$7.0 million in 2024, then soared by 101.58% to $111000.0 in 2025.
  • Per Business Quant, the three most recent readings for EOLS's EBITDA are $111000.0 (Q4 2025), -$15.3 million (Q3 2025), and -$16.9 million (Q2 2025).